Search
Search Results
-
Risk factors for recurrent infection in the surgical treatment of infected massive endoprostheses implanted for musculoskeletal tumours
BackgroundInfection is a devastating complication of endoprosthetic replacement (EPR) in orthopaedic oncology. Surgical treatments include...
-
Carbon-fiber-reinforced polyetheretherketone orthopedic implants in musculoskeletal and spinal tumors: imaging and clinical features
Carbon-fiber-reinforced polyetheretherketone (CFR-PEEK) orthopedic implants are gaining popularity in oncologic applications as they offer many...
-
Musculoskeletal System
Bone is a rigid connective tissue which provides support and protection for the organs and tissues of the body. Certain bones such as the skull,...
-
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors
BackgroundA substantial number of survivors of childhood acute lymphoblastic leukemia (ALL) suffer from treatment-related late adverse effects. While...
-
Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece
PurposeTo perform translation, cross-cultural adaptation, and validation of the Toronto Extremity Salvage Score (TESS) and Musculoskeletal Tumor...
-
A novel core biopsy needle with shorter dead space for percutaneous image-guided musculoskeletal biopsies — how does it compare with an established core biopsy needle?
PurposeTo compare diagnostic yield and utility of a novel core biopsy needle (NCBN) with shortened tip dead space for percutaneous musculoskeletal...
-
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre
BackgroundLike with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in...
-
Musculoskeletal Oncology
Collection focussing on recent developments in bone tumors. -
US Food and Drug Administration regulatory updates in neuro-oncology
ObjectiveContemporary management of patients with neuro-oncologic disease requires an understanding of approvals by the US Food and Drug...
-
Therapy-induced bone changes in oncology imaging with 18F-sodium fluoride (NaF) PET–CT
18 F-Sodium fluoride ( 18 F-NaF) is a PET tracer that is mostly used in the evaluation of bone metastasis in oncology cases. Recently, 18 F-NaF PET/CT is...
-
Neonatal Imaging in Thyroid Disease, Inherited Disease, Syndromes, and Oncology
This chapter spans a wide range of topics, most of them from the field of rare diseases. Neonatal thyroid conditions are discussed, normative values...
-
Pediatric musculoskeletal pathologies: are there differences in triage of diagnoses and preferences for communication between radiology and orthopedics?
ObjectiveTo define the clinical importance of various pediatric musculoskeletal diagnoses, determine preferred communication methods based on the...
-
Pain Management in Oncology
Cancer pain is one of the most dreadful types of pain experienced by the patients and difficult one to treat by the pain physicians; 60–80% cancer...
-
Soft tissue solitary fibrous tumors of the musculoskeletal system: spectrum of MRI appearances and characteristic imaging features
ObjectiveSolitary fibrous tumors (SFTs) uncommonly occur in the musculoskeletal system, with limited available data on their MRI appearance. This...
-
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology
BackgroundGranulocyte colony-stimulating factor (G-CSF) is an essential supportive agent for chemotherapy-induced severe myelosuppression. We...
-
Musculoskeletal Tumors
Bone and soft tissue tumours are not uncommon. Most are benign and do not require more than re-assurance and follow up. However, malignant bone...